Inclusion criteria
pGHD, GHD
GHD
Physicians were eligible if they: (1) provided a signed and dated P-ICF, (2) had treated at least two children (aged ≥3 years and <11 years [for girls]/<12 years [for boys] on the date of P-ICF signature) diagnosed with GHD with once-weekly somatrogon at a clinical site in the phase III trial (NCT02968004), either during the randomization phase or the open-label extension phase, (3) had experience of treating patients with pGHD with once-daily rhGH, and (4) were fluent in English.